Atezolizumab combinations with targeted therapy for anaplastic thyroid carcinoma (ATC).

被引：1
|
作者：
Cabanillas, Maria E.
Dadu, Ramona
Ferrarotto, Renata
Liu, Suyu
Fellman, Bryan M.
Gross, Neil D.
Gule-Monroe, Maria
Lu, Charles
Grosu, Horiana
Williams, Michelle D.
Duose, Dzifa Yawa
Mallampati, Saradhi
Dervin, Shannon
Mckenna, Edward Francis
Wang, Rui Jennifer
Zafereo, Mark
Busaidy, Naifa Lamki
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Div Canc Med, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA
[6] Genentech Inc, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6514
引用
收藏
页数：2
相关论文
共 50 条
  • [41] ANAPLASTIC CARCINOMA OF THYROID
    KYRIAKIDES, G
    ANNALS OF SURGERY, 1974, 179 (03) : 295 - 299
  • [42] Anaplastic carcinoma of the thyroid
    Sweeney, PJ
    Haraf, DJ
    Recant, W
    Kaplan, EL
    Vokes, EE
    ANNALS OF ONCOLOGY, 1996, 7 (07) : 739 - 744
  • [43] Anaplastic Thyroid Carcinoma
    Valente, T.
    Ligabue, M. V.
    Simiao, H. P. C.
    Costa, G. B. C.
    Silva, V. F. D.
    Montemor, C. N.
    Tomarchio, M. P.
    Cambrea, M. F. V.
    Stella, L. C.
    Huayllas, M. K. P.
    Di Nino, F.
    Valente, O.
    Santomauro, A. T.
    Fraige, F. F.
    PROCEEDINGS OF THE 13TH INTERNATIONAL CONGRESS OF ENDOCRINOLOGY, 2008, : 531 - 537
  • [44] Anaplastic Thyroid Carcinoma
    Erickson, Lori A.
    MAYO CLINIC PROCEEDINGS, 2021, 96 (07) : 2008 - 2011
  • [45] Anaplastic thyroid carcinoma
    Shaha, A
    Shindo, M
    Sofferman, R
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2005, 27 (12): : 1102 - 1107
  • [46] Facilitating Anaplastic Specialized Treatments (FAST)-A Multidisciplinary Anaplastic Thyroid Cancer (ATC) Team
    Cabanillas, M. E.
    Gunn, G. B.
    Williams, M. D.
    Busaidy, N. L.
    William, W. N., Jr.
    Lu, C.
    Lai, S. Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (04): : 955 - 955
  • [47] Hypofractionated Radiation in anaplastic Thyroid Carcinoma (ATC) - Systematic Review and Propensity Score Matching (PSM) Study
    Oliinyk, D.
    Augustin, T.
    Koehler, V.
    Rauch, J.
    Belka, C.
    Spitzweg, C.
    Kaesmann, L.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S103 - S103
  • [48] Ceritinib in anaplastic thyroid cancer (ATC) with ALK abnormalities.
    Khan, Saad A.
    Bauman, Julie E.
    Burtness, Barbara
    Frankel, Arthur E.
    Harper, Jessica
    Hughes, Randall S.
    Kurian, Pamela
    Myers, Larry L.
    Nedzi, Lucien Alexander
    Schwartz, David L.
    Sumer, Baran D.
    Truelson, John
    Zhu, Hong
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [49] The American Thyroid Association (ATA) integrates molecular testing into its framework for managing patients with anaplastic thyroid carcinoma (ATC): Update on the 2021 ATA ATC guidelines Comment
    Silver Karcioglu, Amanda
    Iwata, Ayaka J.
    Pusztaszeri, Marc
    Ahmed, Amr
    Randolph, Gregory W.
    CANCER CYTOPATHOLOGY, 2022, 130 (03) : 174 - 180
  • [50] KRAS-SOS-1 Inhibition as New Pharmacological Target to Counteract Anaplastic Thyroid Carcinoma (ATC)
    Mannino, Deborah
    Basilotta, Rossella
    De Luca, Fabiola
    Casili, Giovanna
    Esposito, Emanuela
    Paterniti, Irene
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (06)
12345